Matthew Pink

Company: Biodesix

Job title: Vice President - Business Development

Seminars:

How a Simple Blood Draw & Multi-Omic Testing Can Optimize Cancer Treatment Strategies 11:05 am

ddPCR™ testing drives progress in early cancer diagnosis, personalized therapy, and molecular residual disease detection Proteomic testing can identify a patient’s immune response to cancer; identifying those patients with an aggressive disease state that may benefit from enhanced surveillance, immunotherapy combinations or chemotherapyRead more

day: Day Three Track A